<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font23 { font-size : 23; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font26">and </span>
   <span class="font23">HPV </span>
   <span class="font16">HIV </span>
   <span class="font16">with </span>
   <span class="font16">was </span>
   <span class="font15">women </span>
   <span class="font15">(.) </span>
   <span class="font14">for </span>
   <span class="font13">were </span>
   <span class="font13">{background </span>
   <span class="font13">among </span>
   <span class="font13">genotypes </span>
   <span class="font12">cervical </span>
   <span class="font12">margin </span>
   <span class="font12">study </span>
   <span class="font12">this </span>
   <span class="font12">The </span>
   <span class="font12">are </span>
   <span class="font12">human </span>
   <span class="font12">{border-style </span>
   <span class="font12">that </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">[]. </span>
   <span class="font12">rate </span>
   <span class="font12">from </span>
   <span class="font12">risk </span>
   <span class="font11">infection </span>
   <span class="font11">papillomavirus </span>
   <span class="font11">viral </span>
   <span class="font11">other </span>
   <span class="font11">positivity </span>
   <span class="font11">vs. </span>
   <span class="font11">cancer </span>
   <span class="font11">HR-HPV </span>
   <span class="font11">higher </span>
   <span class="font11">status </span>
   <span class="font11">which </span>
   <span class="font11">(%) </span>
   <span class="font11">Total </span>
   <span class="font11">age </span>
   <span class="font11">those </span>
   <span class="font11">(.% </span>
   <span class="font11">HPV-infection </span>
   <span class="font11">Human </span>
   <span class="font11">all </span>
   <span class="font11">compared </span>
   <span class="font11">could </span>
   <span class="font11">most </span>
   <span class="font11">population </span>
   <span class="font11">virus </span>
   <span class="font11">(/) </span>
   <span class="font11">.%, </span>
   <span class="font11">This </span>
   <span class="font11">associated </span>
   <span class="font11">genotype </span>
   <span class="font11">have </span>
   <span class="font11">not </span>
   <span class="font11">performed </span>
   <span class="font11">prevalence </span>
   <span class="font11">px; </span>
   <span class="font11">{font-family </span>
   <span class="font10">CIRCB </span>
   <span class="font10">Disponible </span>
   <span class="font10">[cité </span>
   <span class="font10">also </span>
   <span class="font10">burden </span>
   <span class="font10">different </span>
   <span class="font10">font-size </span>
   <span class="font10">immunodeficiency </span>
   <span class="font10">load </span>
   <span class="font10">oncogenic </span>
   <span class="font10">sur: </span>
   <span class="font10">than </span>
   <span class="font10">these </span>
   <span class="font10">very </span>
   <span class="font10">women, </span>
   <span class="font10">(Table </span>
   <span class="font10">According </span>
   <span class="font10">HIV-infection </span>
   <span class="font10">HIV-negative </span>
   <span class="font10">HIV-seropositive </span>
   <span class="font10">P-value </span>
   <span class="font10">Table </span>
   <span class="font10">[], </span>
   <span class="font10">according </span>
   <span class="font10">cancers </span>
   <span class="font10">double; </span>
   <span class="font10">genotyping </span>
   <span class="font10">high </span>
   <span class="font10">infected </span>
   <span class="font10">more </span>
   <span class="font10">obtained </span>
   <span class="font10">sexual </span>
   <span class="font10">significantly </span>
   <span class="font10">their </span>
   <span class="font10">using </span>
   <span class="font10">where </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">HIV- </span>
   <span class="font10">HIV-infected </span>
   <span class="font10">International </span>
   <span class="font10">RNA </span>
   <span class="font10">acquiring </span>
   <span class="font10">al. </span>
   <span class="font10">analysis </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">divorced </span>
   <span class="font10">evidence </span>
   <span class="font10">factor </span>
   <span class="font10">immune </span>
   <span class="font10">living </span>
   <span class="font10">median </span>
   <span class="font10">national </span>
   <span class="font10">others </span>
   <span class="font10">participants </span>
   <span class="font10">p = .), </span>
   <span class="font10">screening </span>
   <span class="font10">sexually </span>
   <span class="font10">similar </span>
   <span class="font10">single </span>
   <span class="font10">solid; </span>
   <span class="font10">status, </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Abbott </span>
   <span class="font10">Cameroon </span>
   <span class="font10">Centre </span>
   <span class="font10">Ethics </span>
   <span class="font10">For </span>
   <span class="font10">HIV-positive </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">PLoS </span>
   <span class="font10">Ref </span>
   <span class="font10">Yaoundé, </span>
   <span class="font10">[Internet]. </span>
   <span class="font10">anal </span>
   <span class="font10">been </span>
   <span class="font10">bold </span>
   <span class="font10">clinical </span>
   <span class="font10">co-infection </span>
   <span class="font10">considered </span>
   <span class="font10">copies/ml </span>
   <span class="font10">courier; </span>
   <span class="font10">data </span>
   <span class="font10">detection </span>
   <span class="font10">due </span>
   <span class="font10">em; </span>
   <span class="font10">enrolled </span>
   <span class="font10">following </span>
   <span class="font10">found </span>
   <span class="font10">has </span>
   <span class="font10">high-risk </span>
   <span class="font10">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC/. </span>
   <span class="font10">increasing </span>
   <span class="font10">infections </span>
   <span class="font10">likely </span>
   <span class="font10">marital </span>
   <span class="font10">molecular </span>
   <span class="font10">normal </span>
   <span class="font10">only </span>
   <span class="font10">our </span>
   <span class="font10">papilloma </span>
   <span class="font10">papillomavirus, </span>
   <span class="font10">pt;} </span>
   <span class="font10">p = .). </span>
   <span class="font10">reported </span>
   <span class="font10">samples </span>
   <span class="font10">sept </span>
   <span class="font10">systematic </span>
   <span class="font10">therefore </span>
   <span class="font10">times </span>
   <span class="font10">vaccine </span>
   <span class="font10">viremia </span>
  </p>
 </body>
</html>
